Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03148613
Other study ID # CS-401
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2, 2017
Est. completion date August 30, 2017

Study information

Verified date October 2022
Source Pivot Health Technologies Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prospective, open label, single center clinical study enrolling 70 subjects to study Performance, Human Factors, and Usability for the Carbon Monoxide Breath Sensor System (COBBS)


Description:

Performance: - Non-invasively measure carbon monoxide (CO) levels in the exhaled breath of study subjects using two different types of measurement devices. - Assess the correlation between the measured CO levels (in parts per million, or ppm) of the study CO breath sensor (Carrot Sense) and the predicate CO breath sensor (Bedfont). Human Factors and Usability: - Ensure that representative intended users are able to operate the COBSS independently. - Validate appropriate mitigations of use related hazards identified in risk management documentation. - Uncover previously unforeseen use errors. NOTES: - The study design allows for the assessment of a performance endpoint and human factors endpoint in a single study. - Each participant will complete the study in a single visit which will include the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date August 30, 2017
Est. primary completion date March 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Subject who self-report smoking 2 or more cigarettes each day Inclusion Criteria: - 18-80 years of age - English speaking - Owns and uses a smartphone - Willing to sign the Informed Consent Form Exclusion Criteria: • Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Carbon Monoxide Breath Sensor System (COBSS)
Carbon Monoxide Breath Sensor System (COBSS): Device to measure carbon monoxide levels in one's breath and inform the user.
Bedfont - Micro+™ Smokerlyzer®
Bedfont - Micro+™ Smokerlyzer® : Predicate Device to measure carbon monoxide levels in one's breath.

Locations

Country Name City State
United States Carrot Sense Redwood City California

Sponsors (2)

Lead Sponsor Collaborator
David Utley, MD UserWise

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance Variable - Correlation of Carbon Monoxide (CO) Measurements Between COBSS and Predicate Devices CO concentrations in parts per million (ppm) in exhaled breath from subjects at a single visit will be assessed and reported in order to compare the CO measurements from COBSS to a control (predicate) device. The correlation will be reported as an R value.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.
COBSS breath sample will take approximately 1 minute. Breath sample with the control device will take approximately 1 minute. The breath samples will be collected within 5-10 minutes of each other.
1 minute
Primary Human Factors - User Performance in Use Scenarios Assessment With Observer Ratings User performance of participants in intended use scenarios will be assessed at a single visit. Participants will be observed if they can set up the device, use the device and interpret results. Observer ratings include 'Successful' and 'Unsuccessful'. Specific attention will be given to assess if any harms can occur from observed use errors. Outcome measure data table is tally of participants who were 'Successful' in each use scenario.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.
Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute and assessments will be made over the study session which can last up to 90 minutes.
1 minute for each question; up to 90 minutes for study session
Secondary User Documentation Assessment With Questionnaire With Observer Ratings Participant understanding of user documentation will be assessed at single visit. User documentation includes packaging information, quick start guide, reference card, and user manual. Observer ratings include 'Successful' and 'Unsuccessful'.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.
Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute each. The User documentation assessment portion of the study session will last up to 30 minutes.
The 5-Point Likert Scale for Clarity has the following answer options: 5 - Very Clear; 4 - Clear; 3 - Neither Clear nor Unclear; 2 - Unclear; and 1 - Very Unclear.
Higher values of this scale represent a better outcome, which is greater clarity/understanding.
Up to 90 minutes
Secondary Number of Participants Answering "No" for the Subjective Feedback With Questionnaire Subjective feedback focusing on any concerns (i.e. 'yes', 'no') on using device will be assessed at single visit.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.
*Row title truncated due to character limit. Actual question asked: Were there any points during this portion of the study that you experienced difficulty or had concerns about the product? Subjective feedback focusing on any concerns prior to the conclusion of the study session. Subjective feedback questions will take approximately 1-3 minutes each. The Subjective feedback portion of the study session will last up to 5 to 15 minutes.
Up to 90 minutes
Secondary Participant Assessment With Questionnaire Rating Scales Participant will be asked to provide ratings on the following:
How would you rate the ease or difficulty using the device and phone app? 5 - Very Clear; 4 - Clear; 3 - Neither Clear nor Unclear; 2 - Unclear; 1 - Very Unclear
How easy or difficult was it to understand and interpret the test results?
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes.
Participant will provide the ratings prior to the conclusion of the study session. Participant assessment with questionnaire rating scales will take approximately 1-2 minutes each. The Subjective feedback portion of the study session will last up to 5 minutes.
Up to 90 minutes
See also
  Status Clinical Trial Phase
Completed NCT04133064 - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study N/A
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT03597607 - Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists N/A
Completed NCT05960305 - CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers N/A
Terminated NCT03326128 - High Dose Bupropion for Smoking Cessation - Pilot Study Phase 2
Completed NCT04808609 - Smoking Cessation Pilot for People Living With HIV (PLWH) N/A
Completed NCT04310735 - Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes N/A
Completed NCT03553992 - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers N/A
Enrolling by invitation NCT05554120 - The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation
Completed NCT03015597 - Pilot Study of Contingency Management for Smoking Cessation N/A
Completed NCT05506046 - Messages About Reduced Nicotine in Combusted Tobacco Products N/A
Active, not recruiting NCT04982952 - Contingency Management for Smoking Cessation N/A
Recruiting NCT05992272 - Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
Completed NCT02428244 - Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients N/A
Recruiting NCT03962660 - Harm Reduction for Tobacco Smoking With Support of Tobacco-Replacing Electronic Nicotine Delivery Systems N/A
Completed NCT03200236 - The Lung Screening, Tobacco and Health Project Phase 3
Completed NCT04791722 - Optimizing Smoke-free Residential Housing Policies N/A
Completed NCT02968381 - A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website N/A
Completed NCT06456645 - Effects of Smoking on Placenta and Lactation